© 2026 TPM MEDIA LLC. ALL RIGHTS RESERVED.
coronavirus
CDC Takes Step Back From Guidance Limiting COVID-19 Testing
By
08.27.20 | 1:43 pm
Fauci Was In Surgery As Feds Scaled Back Testing Guidelines, Says He Is Concerned About Their Interpretation
By
08.26.20 | 5:42 pm
HHS Denies It’s Scaling Back COVID Testing Because Of White House Pressure
By
08.26.20 | 4:06 pm
Navarro Dismisses Criticism Of Plasma Treatment For COVID-19 As ‘Crazy Talking Point’
By
08.25.20 | 1:43 pm
BETHESDA, MD - NOVEMBER 21: Nurse Floreliz Mendoza holds the syringe she has used to inject Andie Vaught, 25, with an experimental Zika vaccine as part of a clinical trial at the National Institute of Health Clinical Center in Bethesda, Maryland, November 21, 2016. This vaccine, one of about six or seven in different phases of clinical trial, is currently undergoing safety testing at three locations in the country. Instead of using dead or weakened virus to get the immune system to recognize the infection and fight it off, it uses a piece of DNA engineered to contain genes that code for proteins of the Zika virus. (Photo by Allison Shelley/For The Washington Post) BETHESDA, MD - NOVEMBER 21: Nurse Floreliz Mendoza holds the syringe she has used to inject Andie Vaught, 25, with an experimental Zika vaccine as part of a clinical trial at the National Institute of Health Clinical Center in Bethesda, Maryland, November 21, 2016. This vaccine, one of about six or seven in different phases of clinical trial, is currently undergoing safety testing at three locations in the country. Instead of using dead or weakened virus to get the immune system to recognize the infection and fight it off, it uses a piece of DNA engineered to contain genes that code for proteins of the Zika virus. (Photo by Allison Shelley/For The Washington Post)
Why Trump’s Pressure Campaign On The FDA Will Damage Any COVID-19 Vaccine To Come
By
08.24.20 | 6:05 pm
Trump Will Announce Emergency Authorization For COVID-19 Plasma Treatment
By and
08.23.20 | 3:41 pm
Top Vaccine Official Says He’ll Resign If FDA Caves To Political Pressure
By
08.21.20 | 11:22 am
UNITED STATES - MAY 18: Sen. Bill Cassidy, R-La., leaves a briefing with Deputy Attorney General Rod Rosenstein in the Capitol Visitor Center on the investigation of President Trump's campaign ties to Russia on May 18, 2017. (Photo By Tom Williams/CQ Roll Call) UNITED STATES - MAY 18: Sen. Bill Cassidy, R-La., leaves a briefing with Deputy Attorney General Rod Rosenstein in the Capitol Visitor Center on the investigation of President Trump's campaign ties to Russia on May 18, 2017. (Photo By Tom Williams/CQ Roll Call)
GOP Sen. Bill Cassidy Tests Positive For COVID-19
By
08.20.20 | 2:57 pm
WSJ: Admin Reverses Course, Says CDC Will Regain Control Of COVID Data Collection
By and
08.20.20 | 2:43 pm
HHS Sent Rapid Testing Machines To Nursing Homes Without Direction, Resulting In Mass Confusion
By
08.19.20 | 11:58 am